NCT01920126

Brief Summary

The purpose of study is to test whether perioperative sodium bicarbonate infusion can prevent acute kidney injury following open heart surgery in infective endocarditis patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Aug 2013

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 9, 2013

Completed
4 days until next milestone

Study Start

First participant enrolled

August 13, 2013

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 23, 2016

Completed
Last Updated

July 17, 2018

Status Verified

July 1, 2018

Enrollment Period

3 years

First QC Date

July 31, 2013

Last Update Submit

July 15, 2018

Conditions

Keywords

sodium bicarbonate, renal function, infective endocarditis, open heart surgery

Outcome Measures

Primary Outcomes (1)

  • Comparison of the the peak creatinine level during the postoperative 48h by more than 0.3 mg/dL between two groups.

    We would investigate if the peak creatinine level during the postoperative 48h would differ by more than 0.3 mg/dL between two groups. The primary outcome was decided based on the AKIN criteria which defines acute kidney injury if serum creatinine increases more than 0.3 mg/dL during the postoperative 48 h. ; increase in serum creatinine of 0.3 mg/dL or \>50 percent developing over \<48 hours

    postoperative 48 hours

Study Arms (2)

Sodium bicarbonate group

EXPERIMENTAL

Sodium bicarbonate group

Drug: sodium bicarbonate

Saline group

PLACEBO COMPARATOR

Saline group

Drug: Saline

Interventions

0.5 mmol/kg for 1 hr, and then 0.15 mmol/kg/h for 23 hrs The infusion of study drug is started after anesthesia induction and continued until 24 hours after surgery

Sodium bicarbonate group
SalineDRUG
Saline group

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients over the age of 20 scheduled for open heart surgery for infective endocarditis

You may not qualify if:

  • end stage renal disease (serum creatinine concentration \> 300 μmol/L)
  • on dialysis
  • chronic moderate to high dose corticosteroid therapy (\> 10 mg/day prednisolon or equivalent)
  • preoperative severe hypernatremia (Na+ \> 150 mmol/L), alkalemia (PH \> 7.50), or pulmonary edema
  • neurocognitive dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine

Seoul, 120-752, South Korea

Location

Related Publications (1)

  • Cho JS, Soh S, Shim JK, Kang S, Choi H, Kwak YL. Effect of perioperative sodium bicarbonate administration on renal function following cardiac surgery for infective endocarditis: a randomized, placebo-controlled trial. Crit Care. 2017 Jan 5;21(1):3. doi: 10.1186/s13054-016-1591-z.

MeSH Terms

Conditions

Acute Kidney InjuryEndocarditis

Interventions

Sodium BicarbonateSodium Chloride

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesHeart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

BicarbonatesCarbonatesCarbonic AcidCarbon Compounds, InorganicInorganic ChemicalsSodium CompoundsChloridesHydrochloric AcidChlorine Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2013

First Posted

August 9, 2013

Study Start

August 13, 2013

Primary Completion

August 23, 2016

Study Completion

August 23, 2016

Last Updated

July 17, 2018

Record last verified: 2018-07

Locations